jueves, 18 de febrero de 2010

Interferon-alfa in the treatment of patients with inoperable locally advanced metastatic renal cell cancer: guideline recommendations


GUIDELINE TITLE
Interferon-alfa in the treatment of patients with inoperable locally advanced metastatic renal cell cancer: guideline recommendations.

BIBLIOGRAPHIC SOURCE(S)
Canil C, Hotte S, Mayhew LA, Waldron T, Winquist E, Genitourinary Cancer Disease Site Group. Interferon-alfa in the treatment of patients with inoperable locally advanced or metastatic renal cell cancer: guideline recommendations. Toronto (ON): Cancer Care Ontario (CCO); 2009 May 12. 26 p. (Evidence based series; no. 3-8-1). [39 references]


GUIDELINE STATUS
This is the current release of the guideline.

The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=44111

abrir aquí para acceder al documento NGC AHRQ completo:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=15043&nbr=&string=

No hay comentarios:

Publicar un comentario